439 related articles for article (PubMed ID: 34649567)
21. Musashi 2 contributes to the stemness and chemoresistance of liver cancer stem cells via LIN28A activation.
Fang T; Lv H; Wu F; Wang C; Li T; Lv G; Tang L; Guo L; Tang S; Cao D; Wu M; Yang W; Wang H
Cancer Lett; 2017 Jan; 384():50-59. PubMed ID: 27721018
[TBL] [Abstract][Full Text] [Related]
22. ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation.
Lin Q; Wu Z; Yue X; Yu X; Wang Z; Song X; Xu L; He Y; Ge Y; Tan S; Wang T; Song H; Yuan D; Gong Y; Gao L; Liang X; Ma C
EBioMedicine; 2020 Mar; 53():102676. PubMed ID: 32114388
[TBL] [Abstract][Full Text] [Related]
23. lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal.
Zhu P; Wang Y; Huang G; Ye B; Liu B; Wu J; Du Y; He L; Fan Z
Nat Struct Mol Biol; 2016 Jul; 23(7):631-9. PubMed ID: 27239797
[TBL] [Abstract][Full Text] [Related]
24. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
25. Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.
Wang L; Long H; Zheng Q; Bo X; Xiao X; Li B
Mol Cancer; 2019 Jul; 18(1):119. PubMed ID: 31324186
[TBL] [Abstract][Full Text] [Related]
26. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
Li B; Liu D; Yang P; Li HY; Wang D
Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
[TBL] [Abstract][Full Text] [Related]
27. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
Huang WC; Tung SL; Chen YL; Chen PM; Chu PY
BMC Cancer; 2018 May; 18(1):609. PubMed ID: 29848298
[TBL] [Abstract][Full Text] [Related]
28. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
[TBL] [Abstract][Full Text] [Related]
29. miR-194 inhibits liver cancer stem cell expansion by regulating RAC1 pathway.
Ran RZ; Chen J; Cui LJ; Lin XL; Fan MM; Cong ZZ; Zhang H; Tan WF; Zhang GQ; Zhang YJ
Exp Cell Res; 2019 May; 378(1):66-75. PubMed ID: 30844391
[TBL] [Abstract][Full Text] [Related]
30. lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2.
Yang S; Ruan X; Hu B; Tu J; Cai H
Cell Tissue Res; 2023 Dec; 394(3):441-453. PubMed ID: 37851112
[TBL] [Abstract][Full Text] [Related]
31. miR-206 inhibits liver cancer stem cell expansion by regulating EGFR expression.
Liu C; Li J; Wang W; Zhong X; Xu F; Lu J
Cell Cycle; 2020 May; 19(10):1077-1088. PubMed ID: 32286127
[TBL] [Abstract][Full Text] [Related]
32. IRAK1 Augments Cancer Stemness and Drug Resistance via the AP-1/AKR1B10 Signaling Cascade in Hepatocellular Carcinoma.
Cheng BY; Lau EY; Leung HW; Leung CO; Ho NP; Gurung S; Cheng LK; Lin CH; Lo RC; Ma S; Ng IO; Lee TK
Cancer Res; 2018 May; 78(9):2332-2342. PubMed ID: 29483095
[TBL] [Abstract][Full Text] [Related]
33. CXCL11 promotes self-renewal and tumorigenicity of α2δ1
Zhang Y; Zhao W; Li S; Lv M; Yang X; Li M; Zhang Z
Cancer Lett; 2019 May; 449():163-171. PubMed ID: 30771435
[TBL] [Abstract][Full Text] [Related]
34. Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via a Wnt Positive-Signaling Loop by Stabilization of Low-Density Lipoprotein-Receptor-Related Proteins 5 and 6.
Lai KKY; Kweon SM; Chi F; Hwang E; Kabe Y; Higashiyama R; Qin L; Yan R; Wu RP; Lai K; Fujii N; French S; Xu J; Wang JY; Murali R; Mishra L; Lee JS; Ntambi JM; Tsukamoto H
Gastroenterology; 2017 May; 152(6):1477-1491. PubMed ID: 28143772
[TBL] [Abstract][Full Text] [Related]
35. TLR4 increases the stemness and is highly expressed in relapsed human hepatocellular carcinoma.
Zhou S; Du R; Wang Z; Shen W; Gao R; Jiang S; Fang Y; Shi Y; Chang A; Liu L; Liu C; Li N; Xiang R
Cancer Med; 2019 May; 8(5):2325-2337. PubMed ID: 30957973
[TBL] [Abstract][Full Text] [Related]
36. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
37. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
[TBL] [Abstract][Full Text] [Related]
38. Let-7 inhibits self-renewal of hepatocellular cancer stem-like cells through regulating the epithelial-mesenchymal transition and the Wnt signaling pathway.
Jin B; Wang W; Meng XX; Du G; Li J; Zhang SZ; Zhou BH; Fu ZH
BMC Cancer; 2016 Nov; 16(1):863. PubMed ID: 27821157
[TBL] [Abstract][Full Text] [Related]
39. Zinc finger protein X-linked promotes expansion of EpCAM
Wang C; Fu SY; Wang MD; Yu WB; Cui QS; Wang HR; Huang H; Dong W; Zhang WW; Li PP; Lin C; Pan ZY; Yang Y; Wu MC; Zhou WP
Mol Oncol; 2017 May; 11(5):455-469. PubMed ID: 28156061
[TBL] [Abstract][Full Text] [Related]
40. PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer.
Wu J; Tan HY; Chan YT; Lu Y; Feng Z; Yuan H; Zhang C; Feng Y; Wang N
J Exp Clin Cancer Res; 2024 Feb; 43(1):42. PubMed ID: 38317186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
